MA
BSX icon

MONECO Advisors’s Boston Scientific BSX Stock Holding History

MONECO Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,909
Closed -$245K – 600
2026
Q1 		$245K Sell
3,909
-883
-18% -$70.6K 0.02% 452
2025
Q4 		$457K Sell
4,792
-57
-1% -$5.59K 0.04% 315
2025
Q3 		$473K Buy
4,849
+1,079
+29% +$112K 0.04% 315
2025
Q2 		$405K Sell
3,770
-272
-7% -$27.5K 0.04% 333
2025
Q1 		$408K Sell
4,042
-323
-7% -$32.5K 0.04% 313
2024
Q4 		$390K Buy
4,365
+504
+13% +$44.4K 0.04% 325
2024
Q3 		$324K Buy
3,861
+272
+8% +$21.4K 0.04% 328
2024
Q2 		$276K Buy
3,589
+106
+3% +$7.76K 0.04% 337
2024
Q1 		$239K Sell
3,483
-438
-11% -$28.2K 0.04% 362
2023
Q4 		$227K Buy
3,921
+17
+0.4% +$907 0.04% 341
2023
Q3 		$206K Buy
+3,904
New +$205K 0.06% 320

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MONECO Advisors's BSX Position: Q2 2026 in Review

MONECO Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,909 shares — an estimated $245K sold.

MONECO Advisors first reported a position in BSX in Q3 2023 and held it in 11 quarters. The position peaked at $473K in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • MONECO Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • MONECO Advisors sold 3,909 Boston Scientific shares in Q2 2026, an estimated $245K.
  • MONECO Advisors first reported a position in Boston Scientific in Q3 2023 and held it in 11 quarters.
  • MONECO Advisors's Boston Scientific position peaked at $473K in Q3 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on MONECO Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.